Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jso.26057 http://scihub22266oqcxt.onion/10.1002/jso.26057 32476155!7300981!32476155     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32476155&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Surg+Oncol 2020 ; 122 (2): 122-123 Nephropedia Template TP {{tp|p=32476155|t=2020. Management of patients with ovarian cancer in the COVID-19 era |pdf=|usr=}}{{32476155}} gab.com Text Management of patients with ovarian cancer in the COVID-19 era JO: J Surg Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32476155 #FOAvip At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment. Twit Text FOAVip Management of patients with ovarian cancer in the COVID-19 era ????J Surg Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32476155 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32476155 #FOAvip English Wikipedia <ref>{{Cite pmid|32476155}}</ref> Management of patients with ovarian cancer in the COVID-19 era #MMPMID32476155 Bogani G; Casarin J; Pinelli C; Di Donato V; Bosio S; Ruisi S; Brusadelli C; Guerrisi R; Sarpietro G; Ditto A; Ghezzi F; Raspagliesi F J Surg Oncol 2020[Aug]; 122 (2): 122-123 PMID32476155show ga At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment. |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/epidemiology/*prevention & control/transmission[MESH] |Female[MESH] |Gynecologic Surgical Procedures/methods/standards[MESH] |Humans[MESH] |Infection Control/methods/standards[MESH] |Infectious Disease Transmission, Patient-to-Professional/prevention & control[MESH] |Laparoscopy/methods/standards[MESH] |Ovarian Neoplasms/*surgery/virology[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/epidemiology/*prevention & control/transmission[MESH] |SARS-CoV-2[MESH]Management of patients with ovarian cancer in the COVID-19 era (epmc).pdf DeepDyve Pubget Overpricing